Intrexon climbs on Griffin Securities initiation

|About: Intrexon Corp (XON)|By:, SA News Editor

Shares of Intrexon (XON +4.3%) climb after Griffin Securities initiates the synthetic biotech at Buy with a PT of $36 (potential upside of 56.5%).

Griffin joins JPMorgan and Mizuho, who carry Overweight and Buy ratings respectively on XON and a PT of $30.